Oberweis Asset Management Inc Amgen Inc Transaction History

Oberweis Asset Management Inc

$1.57 Billion
Q2 2024

A detailed history of Oberweis Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Oberweis Asset Management Inc holds 1,071 shares of AMGN stock, worth $338,436. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,071

Previous 1,070 0.09%

Holding current value

$338,436

Previous $304,000 9.87%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.09%	1,071 $334,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $268 - $324	1 Added 0.09%	1,070 $304,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $39,633 - $44,711	-155 Reduced 12.66%	1,069 $307,000
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $34,765 - $43,162	-159 Reduced 11.5%	1,224 $328,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $214 - $253	1 Added 0.07%	1,383 $307,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $225 - $275	1 Added 0.07%	1,382 $334,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.07%	1,381 $362,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.07%	1,380 $311,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $219 - $242	1 Added 0.07%	1,379 $333,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $23,666 - $27,084	-119 Reduced 7.95%	1,378 $310,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $212 - $248	1 Added 0.07%	1,497 $318,000
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.07%	1,496 $365,000
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $221 - $258	1 Added 0.07%	1,495 $372,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $216 - $257	1 Added 0.07%	1,494 $344,000
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $3,758 - $4,612	-19 Reduced 1.26%	1,493 $352,000
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $182 - $241	1 Added 0.07%	1,512 $307,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $189 - $243	1 Added 0.07%	1,511 $364,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $12,535 - $15,020	-72 Reduced 4.55%	1,510 $292,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $166 - $195	1 Added 0.06%	1,582 $292,000
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.13%	1,581 $300,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $535 - $624	3 Added 0.19%	1,579 $307,000
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $185 - $208	-1 Reduced 0.06%	1,576 $327,000
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $11,955 - $13,428	-72 Reduced 4.37%	1,577 $291,000
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $41,691 - $46,581	-247 Reduced 13.03%	1,649 $287,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $317,181 - $362,136	1,896	1,896 $354,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.

Account

Oberweis Asset Management Inc Amgen Inc Transaction History